Dr Lalchandani Labs has obtained regulatory approval to postpone its Annual General Meeting (AGM) for FY26 until December 31, 2026. The company cited the ill health of its Chairperson as the primary reason for seeking the extension.

The Registrar of Companies (ROC), Delhi, granted a three-month extension under Section 96(1) of the Companies Act, 2013. The AGM was originally scheduled to be held on or before September 30, 2026. The company submitted its application on September 15, 2026, and received approval on September 17, 2026.

Regulatory Compliance

The ROC order mandates that the company hold the meeting at the earliest possible date but no later than December 31, 2026. The regulator advised the company to ensure timely compliance with statutory provisions in future filings.

The exact date, venue, and notice for the rescheduled AGM will be communicated separately. Mohit Lalchandani, Whole Time Director, signed the announcement confirming the regulatory approval.

Dr Lalchandani Labs Limited returned to profitability in the financial year ended March 31, 2026, reporting a net profit of ₹6.35 lakh compared to a loss of ₹13.15 lakh in the previous year. The turnaround was driven by a one-time settlement gain of ₹61.08 lakh booked under exceptional items, which offset operational challenges. Revenue from operations for the year stood at ₹418.58 lakh, a slight decline from ₹445.38 lakh in FY25, while total expenses decreased to ₹418.04 lakh from ₹470.05 lakh in the prior year.

The Board of Directors, at its meeting held on June 03, 2026, approved the audited standalone financial results for the year and half-year ended March 31, 2026. The meeting also saw the appointment of M/s. Brickwork Ratings India Private Limited as the Monitoring Agency for the utilization of Rights Issue Proceeds, replacing M/s. Infomerics Valuation and Ratings Limited. The trading window for the company's securities will remain closed until 48 hours after the declaration of the results, in accordance with SEBI regulations.

The financial statements were subject to a qualified opinion from the statutory auditor, ATN & CO. The qualifications highlighted that the company's accounts with lenders have been classified as Non-Performing Assets (NPA), and no working capital limit was sanctioned or renewed during the year. Additionally, the company has defaulted on the repayment of term loans and unsecured loans despite having significant cash and cash equivalents. The auditors also noted that statutory dues for PF and ESIC have not been paid for the current and previous financial years, and provisions for gratuity and leave encashment liabilities have not been made in compliance with Accounting Standard-15.

Financial Performance for FY26

The company stated that the impact of the audit qualifications has been adjusted and accounted for in the audited financials to the extent quantifiable. The Board also reviewed the unaudited results for the half-year ended September 30, 2025, which showed a net loss of ₹2.65 lakh.